Copyright Reports & Markets. All rights reserved.

Global Therapeutic Peptide Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Therapeutic Peptide Market Status and Forecast (2017-2028)
      • 1.3.2 Global Therapeutic Peptide Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Therapeutic Peptide Supply by Company

    • 2.1 Global Therapeutic Peptide Sales Volume by Company
    • 2.2 Global Therapeutic Peptide Sales Value by Company
    • 2.3 Global Therapeutic Peptide Price by Company
    • 2.4 Therapeutic Peptide Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Therapeutic Peptide Market Status by Type

    • 3.1 Therapeutic Peptide Type Introduction
      • 3.1.1 Oral
      • 3.1.2 Injection
      • 3.1.3 Other
    • 3.2 Global Therapeutic Peptide Market by Type
      • 3.2.1 Global Therapeutic Peptide Sales Volume by Type (2017-2022)
      • 3.2.2 Global Therapeutic Peptide Sales Value by Type (2017-2022)
      • 3.2.3 Global Therapeutic Peptide Price by Type (2017-2022)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Therapeutic Peptide Market Status by Application

    • 4.1 Therapeutic Peptide Segment by Application
      • 4.1.1 Cancer
      • 4.1.2 Metabolic Disorders
      • 4.1.3 Central Nervous System
      • 4.1.4 Other
    • 4.2 Global Therapeutic Peptide Market by Application
      • 4.2.1 Global Therapeutic Peptide Sales Volume by Application (2017-2022)
      • 4.2.2 Global Therapeutic Peptide Sales Value by Application (2017-2022)
      • 4.2.3 Global Therapeutic Peptide Price by Application (2017-2022)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Therapeutic Peptide Market Status by Region

    • 5.1 Global Therapeutic Peptide Market by Region
      • 5.1.1 Global Therapeutic Peptide Sales Volume by Region
      • 5.1.2 Global Therapeutic Peptide Sales Value by Region
    • 5.2 North America Therapeutic Peptide Market Status
    • 5.3 Europe Therapeutic Peptide Market Status
    • 5.4 Asia Pacific Therapeutic Peptide Market Status
    • 5.5 Central & South America Therapeutic Peptide Market Status
    • 5.6 Middle East & Africa Therapeutic Peptide Market Status

    6 North America Therapeutic Peptide Market Status

    • 6.1 North America Therapeutic Peptide Market by Country
      • 6.1.1 North America Therapeutic Peptide Sales Volume by Country (2017-2022)
      • 6.1.2 North America Therapeutic Peptide Sales Value by Country (2017-2022)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Therapeutic Peptide Market Status

    • 7.1 Europe Therapeutic Peptide Market by Country
      • 7.1.1 Europe Therapeutic Peptide Sales Volume by Country (2017-2022)
      • 7.1.2 Europe Therapeutic Peptide Sales Value by Country (2017-2022)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Therapeutic Peptide Market Status

    • 8.1 Asia Pacific Therapeutic Peptide Market by Country
      • 8.1.1 Asia Pacific Therapeutic Peptide Sales Volume by Country (2017-2022)
      • 8.1.2 Asia Pacific Therapeutic Peptide Sales Value by Country (2017-2022)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Therapeutic Peptide Market Status

    • 9.1 Central & South America Therapeutic Peptide Market by Country
      • 9.1.1 Central & South America Therapeutic Peptide Sales Volume by Country (2017-2022)
      • 9.1.2 Central & South America Therapeutic Peptide Sales Value by Country (2017-2022)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Therapeutic Peptide Market Status

    • 10.1 Middle East & Africa Therapeutic Peptide Market by Country
      • 10.1.1 Middle East & Africa Therapeutic Peptide Sales Volume by Country (2017-2022)
      • 10.1.2 Middle East & Africa Therapeutic Peptide Sales Value by Country (2017-2022)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Therapeutic Peptide Manufacturing Cost Analysis
    • 11.5 Therapeutic Peptide Sales Channel and Distributors Analysis
      • 11.5.1 Therapeutic Peptide Sales Channel
      • 11.5.2 Therapeutic Peptide Distributors
    • 11.6 Therapeutic Peptide Downstream Major Buyers

    12 Global Therapeutic Peptide Market Forecast by Type and by Application

    • 12.1 Global Therapeutic Peptide Sales Volume and Sales Value Forecast (2023-2028)
    • 12.2 Global Therapeutic Peptide Forecast by Type
      • 12.2.1 Global Therapeutic Peptide Sales Volume Forecast by Type
      • 12.2.2 Global Therapeutic Peptide Sales Value Forecast by Type
      • 12.2.3 Global Therapeutic Peptide Price Forecast by Type
    • 12.3 Global Therapeutic Peptide Forecast by Application
      • 12.3.1 Global Therapeutic Peptide Sales Volume Forecast by Application
      • 12.3.2 Global Therapeutic Peptide Sales Value Forecast by Application
      • 12.3.3 Global Therapeutic Peptide Price Forecast by Application

    13 Global Therapeutic Peptide Market Forecast by Region/Country

    • 13.1 Global Therapeutic Peptide Market Forecast by Region (2023-2028)
      • 13.1.1 Global Therapeutic Peptide Sales Volume Forecast by Region (2023-2028)
      • 13.1.2 Global Therapeutic Peptide Sales Value Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teva
      • 14.1.1 Company Information
      • 14.1.2 Therapeutic Peptide Product Introduction
      • 14.1.3 Teva Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Takeda
      • 14.2.1 Company Information
      • 14.2.2 Therapeutic Peptide Product Introduction
      • 14.2.3 Takeda Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Sanofi
      • 14.3.1 Company Information
      • 14.3.2 Therapeutic Peptide Product Introduction
      • 14.3.3 Sanofi Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 Novo Nordisk
      • 14.4.1 Company Information
      • 14.4.2 Therapeutic Peptide Product Introduction
      • 14.4.3 Novo Nordisk Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Novartis
      • 14.5.1 Company Information
      • 14.5.2 Therapeutic Peptide Product Introduction
      • 14.5.3 Novartis Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Merck
      • 14.6.1 Company Information
      • 14.6.2 Therapeutic Peptide Product Introduction
      • 14.6.3 Merck Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 Johnson and Johnson
      • 14.7.1 Company Information
      • 14.7.2 Therapeutic Peptide Product Introduction
      • 14.7.3 Johnson and Johnson Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Ipsen
      • 14.8.1 Company Information
      • 14.8.2 Therapeutic Peptide Product Introduction
      • 14.8.3 Ipsen Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.8.4 SWOT Analysis
    • 14.9 Eli Lilly
      • 14.9.1 Company Information
      • 14.9.2 Therapeutic Peptide Product Introduction
      • 14.9.3 Eli Lilly Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.9.4 SWOT Analysis
    • 14.10 AstraZeneca
      • 14.10.1 Company Information
      • 14.10.2 Therapeutic Peptide Product Introduction
      • 14.10.3 AstraZeneca Therapeutic Peptide Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
      • 14.10.4 SWOT Analysis
    • 14.11 AbbVie

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Therapeutic Peptide market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Therapeutic Peptide industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Therapeutic Peptide market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Therapeutic Peptide Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Peptide market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Therapeutic Peptide Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Therapeutic Peptide industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Oral
      Injection

      Segmented by Application
      Cancer
      Metabolic Disorders
      Central Nervous System
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Sanofi
      Novo Nordisk
      Novartis
      Merck
      Johnson and Johnson
      Ipsen
      Eli Lilly
      AstraZeneca
      AbbVie
      Buy now